How Technology Is Changing How We Treat Varicose Vein Treatment
The global varicose vein treatment market was valued at $376.64 million in 2017, and is expected to reach $589.06 million by 2025, registering a CAGR of 5.7% from 2018 to 2025. Varicose veins are abnormal, dilated blood vessels caused by weakening of the vessel's walls. These veins appear to be swollen, twisted, cluster of blue or purple veins under the skin. Varicose vein disorder affects millions of people all around the world Symptoms usually appear at the age of 40 and generally appear in the legs. Varicose vein is harmful to health if they lead to venous stasis ulcers, phlebitis, thrombosis, venous hemorrhage, or fungal and bacterial infections. According to the American Society of Vascular surgery, at least 20 to 25 million Americans are suffering from varicose vein, among them 17% are men and 33% are women.
Get PDF Brochure: https://bit.ly/2Yvtr1o

Get PDF Brochure: https://bit.ly/2Yvtr1o

Varicose Vein Treatment Market Segment by Manufacturers
includes:
Alma Lasers Ltd, Angiodynamics, Inc, Biolitec AG, BTG PLC,
Energist Ltd, Medtronic, Lumenis, Sciton Inc, Syneron, WONTECH Co., Ltd.
Comments
Post a Comment